INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy.

By B. Minsky, T. Pajak, R. Ginsberg, T. Pisansky, J. Martenson, R. Komaki, G. Okawara, S. Rosenthal, D. Kelsen. Journal of Clinical Oncology, 2002

1,453 citations recorded by the source corpus.